CVE-2018-10239

Description

A privilege escalation vulnerability in the "support access" feature on Infoblox NIOS 6.8 through 8.4.1 could allow a locally authenticated administrator to temporarily gain additional privileges on an affected device and perform actions within the super user scope. The vulnerability is due to a weakness in the "support access" password generation algorithm. A locally authenticated administrative user may be able to exploit this vulnerability if the "support access" feature is enabled, they know the support access code for the current session, and they know the algorithm to generate the support access password from the support access code. "Support access" is disabled by default. When enabled, the access will be automatically disabled (and support access code will expire) after the 24 hours.

Category

6.7
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.12%
Vendor Advisory infoblox.com
Affected: n/a n/a
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2018-10239?
CVE-2018-10239 has been scored as a medium severity vulnerability.
How to fix CVE-2018-10239?
To fix CVE-2018-10239, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-10239 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-10239 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.